Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Total Current Liabilities

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Total Current Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Total Current Liabilities ₹6,507 Cr₹5,664 Cr₹2,120 Cr₹1,863 Cr₹2,623 Cr

What is the latest Total Current Liabilities ratio of MANKIND PHARMA ?

The latest Total Current Liabilities ratio of MANKIND PHARMA is ₹6,507 Cr based on Mar2026 Consolidated results.
Year Total Current Liabilities
Mar2026₹6,507 Cr
Mar2025₹5,664 Cr
Mar2024₹2,120 Cr
Mar2023₹1,863 Cr
Mar2022₹2,623 Cr

How is Total Current Liabilities of MANKIND PHARMA Trending?

Years Total Current Liabilities % Change
Mar2026 ₹6,507 Cr
14.90
Mar2025 ₹5,664 Cr
167.18
Mar2024 ₹2,120 Cr
13.77
Mar2023 ₹1,863 Cr
-28.98
Mar2022 ₹2,623 Cr -

Compare Total Current Liabilities of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹108,129.6 Cr 2.9% 5.4% -3.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹474,396.0 Cr 1.8% 5.6% 16.7% Stock Analytics
DIVIS LABORATORIES ₹196,990.0 Cr 0.5% 13.1% 10.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹186,354.0 Cr -2.7% 5.1% 42.4% Stock Analytics
CIPLA ₹116,705.0 Cr 2.1% -0.6% -4.5% Stock Analytics
DR REDDYS LABORATORIES ₹94,790.0 Cr -4% -17.5% -8.6% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

2.9%

5.4%

-3.6%

SENSEX

-0.9%

-0.4%

-6.1%


You may also like the below Video Courses